Allena Pharmaceuticals Operating Expenses 2011-2026 | ALNA

Annual Operating Expenses Allena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
47.6 M	32 M	46.9 M	35.6 M	21 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
47.6 M	21 M	36.6 M

Quarterly Operating Expenses Allena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	6.92 M	11.6 M	10.1 M	12.4 M	13.7 M	11.4 M	9.98 M	7.92 M	6.56 M	7.52 M	11.3 M	13.3 M	11.3 M	11.6 M	9.78 M	9.7 M	8.14 M	7.97 M	6.57 M	4.36 M	4.48 M	5.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.7 M	4.36 M	9.19 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
ANI Pharmaceuticals ANIP	127 M	$ 80.89	-1.35 %	$ 1.56 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Amgen AMGN	9.33 B	$ 341.41	-0.45 %	$ 183 B	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.68	3.88 %	$ 16.8 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.23	-1.01 %	$ 7.77 B	Australia
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Biogen BIIB	5.39 B	$ 177.21	0.61 %	$ 25.8 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Beam Therapeutics BEAM	479 M	$ 28.43	-2.94 %	$ 2.34 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Ascendis Pharma A/S ASND	338 M	$ 224.26	0.14 %	$ 5 B	Danmark
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	512 M	$ 115.04	-1.49 %	$ 27.2 B	Germany
Burford Capital Limited BUR	106 M	$ 9.65	-	$ 1.52 B	Britain
Arrowhead Pharmaceuticals ARWR	731 M	$ 68.78	-0.5 %	$ 9.2 B	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
CASI Pharmaceuticals CASI	38.9 M	$ 1.01	1.6 %	$ 137 M	USA
Catalyst Biosciences CBIO	176 M	$ 9.79	-3.55 %	$ 644 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.0	-3.61 %	$ 8.7 B	Israel
Amneal Pharmaceuticals AMRX	539 M	$ 14.0	-0.78 %	$ 4.33 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Cerus Corporation CERS	135 M	$ 2.28	-1.94 %	$ 421 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA